These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37956910)

  • 21. Von Willebrand Factor Aggravates Hepatic Ischemia-Reperfusion Injury by Promoting Neutrophil Recruitment in Mice.
    Urisono Y; Sakata A; Matsui H; Kasuda S; Ono S; Yoshimoto K; Nishio K; Sho M; Akiyama M; Miyata T; Okuchi K; Nishimura S; Sugimoto M
    Thromb Haemost; 2018 Apr; 118(4):700-708. PubMed ID: 29618155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carboxyl terminus of ADAMTS13 directly inhibits platelet aggregation and ultra large von Willebrand factor string formation under flow in a free-thiol-dependent manner.
    Bao J; Xiao J; Mao Y; Zheng XL
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):397-407. PubMed ID: 24357063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The p.R1819_C1948delinsS mutation makes von Willebrand factor ADAMTS13-resistant and reduces its collagen-binding capacity.
    Daidone V; Saga G; Barbon G; Pontara E; Cattini MG; Morpurgo M; Zanotti G; Casonato A
    Br J Haematol; 2015 Aug; 170(4):564-73. PubMed ID: 25904363
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Apolipoprotein B100/Low-Density Lipoprotein Regulates Proteolysis and Functions of von Willebrand Factor under Arterial Shear.
    Cao W; Abdelgawwad MS; Li J; Zheng XL
    Thromb Haemost; 2019 Dec; 119(12):1933-1946. PubMed ID: 31493779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of von Willebrand factor by ADAMTS13 ameliorates lipopolysaccharide-induced lung injury in mice.
    Onodera Y; Mitani S; Hosoda C; Takabayashi Y; Sakata A; Kawasaki R; Mori R; Ohshima C; Nishio K; Sugimoto M; Soejima K; Mackman N; Shima M; Tatsumi K
    Int J Hematol; 2023 Dec; 118(6):699-710. PubMed ID: 37759076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levels and activities of von Willebrand factor and metalloproteinase with thrombospondin type-1 motif, number 13 in inflammatory bowel diseases.
    Cibor D; Owczarek D; Butenas S; Salapa K; Mach T; Undas A
    World J Gastroenterol; 2017 Jul; 23(26):4796-4805. PubMed ID: 28765701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultralarge von Willebrand factor fibers mediate luminal Staphylococcus aureus adhesion to an intact endothelial cell layer under shear stress.
    Pappelbaum KI; Gorzelanny C; Grässle S; Suckau J; Laschke MW; Bischoff M; Bauer C; Schorpp-Kistner M; Weidenmaier C; Schneppenheim R; Obser T; Sinha B; Schneider SW
    Circulation; 2013 Jul; 128(1):50-9. PubMed ID: 23720451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of total flavonoids of Engelhardia roxburghiana Wall. leaves against radiation-induced intestinal injury in mice and its mechanism.
    Wu S; Tian C; Tu Z; Guo J; Xu F; Qin W; Chang H; Wang Z; Hu T; Sun X; Ning H; Li Y; Gou W; Hou W
    J Ethnopharmacol; 2023 Jul; 311():116428. PubMed ID: 36997130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Light chain of factor VIII is sufficient for accelerating cleavage of von Willebrand factor by ADAMTS13 metalloprotease.
    Cao W; Sabatino DE; Altynova E; Lange AM; Casina VC; Camire RM; Zheng XL
    J Biol Chem; 2012 Sep; 287(39):32459-66. PubMed ID: 22854959
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosite interactions contribute to tension-induced cleavage of von Willebrand factor by the antithrombotic ADAMTS13 metalloprotease.
    Gao W; Anderson PJ; Majerus EM; Tuley EA; Sadler JE
    Proc Natl Acad Sci U S A; 2006 Dec; 103(50):19099-104. PubMed ID: 17146059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Formation and Resolution of Pial Microvascular Thrombosis in a Mouse Model of Thrombotic Thrombocytopenic Purpura.
    Adili R; Holinstat M
    Arterioscler Thromb Vasc Biol; 2019 Sep; 39(9):1817-1830. PubMed ID: 31340669
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ADAMTS13 cleavage efficiency is altered by mutagenic and, to a lesser extent, polymorphic sequence changes in the A1 and A2 domains of von Willebrand factor.
    Pruss CM; Notley CR; Hegadorn CA; O'Brien LA; Lillicrap D
    Br J Haematol; 2008 Nov; 143(4):552-8. PubMed ID: 18986390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher and lower active circulating VWF levels: different facets of von Willebrand disease.
    Casonato A; Pontara E; Morpurgo M; Sartorello F; De Groot PG; Cattini MG; Daidone V; De Marco L
    Br J Haematol; 2015 Dec; 171(5):845-53. PubMed ID: 26456374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations between the von Willebrand Factor-ADAMTS13 Axis, Complement Activation, and COVID-19 Severity and Mortality.
    Sinkovits G; Réti M; Müller V; Iványi Z; Gál J; Gopcsa L; Reményi P; Szathmáry B; Lakatos B; Szlávik J; Bobek I; Prohászka ZZ; Förhécz Z; Mező B; Csuka D; Hurler L; Kajdácsi E; Cervenak L; Kiszel P; Masszi T; Vályi-Nagy I; Prohászka Z
    Thromb Haemost; 2022 Feb; 122(2):240-256. PubMed ID: 35062036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [von Willebrand factor and von Willebrand disease].
    Matsui T; Hamako J
    Rinsho Ketsueki; 2016; 57(10):2113-2123. PubMed ID: 27795521
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Modeling ADAMTS13-von Willebrand factor interaction: Implications for oxidative stress-related cardiovascular diseases and type 2A von Willebrand disease.
    Pozzi N; Lancellotti S; De Cristofaro R; De Filippis V
    Biophys Chem; 2012 Jan; 160(1):1-11. PubMed ID: 21937160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment with recombinant ADAMTS13, alleviates hypoxia/reoxygenation-induced pathologies in a mouse model of human sickle cell disease.
    Rossato P; Glantschnig H; Canneva F; Schuster M; Coulibaly S; Schrenk G; Voelkel D; Dockal M; Plaimauer B; Rottensteiner H; Gritsch H; Federti E; Matte A; De Franceschi L; Scheiflinger F; Hoellriegl W
    J Thromb Haemost; 2023 Feb; 21(2):269-275. PubMed ID: 36700507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall.
    Rybaltowski M; Suzuki Y; Mogami H; Chlebinska I; Brzoska T; Tanaka A; Banno F; Miyata T; Urano T
    Pflugers Arch; 2011 Jun; 461(6):623-33. PubMed ID: 21494805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreased von Willebrand factor ristocetin cofactor activity and increased ADAMTS13 antigen increase postoperative drainage after coronary artery bypass grafting.
    Mazur P; Plicner D; Zdziarska J; Sadowski J; Undas A
    Eur J Cardiothorac Surg; 2014 Feb; 45(2):e26-32. PubMed ID: 24351199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phylogenetic and functional analysis of ADAMTS13 identifies highly conserved domains essential for allosteric regulation.
    Muia J; Zhu J; Greco SC; Vanhoorelbeke K; Gupta G; Westfield LA; Sadler JE
    Blood; 2019 Apr; 133(17):1899-1908. PubMed ID: 30700419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.